Table 1

T-tests estimating support for funding prevention of PrEP, diabetes and HPV

HIVDiabetesHPV
Lifestyle3.73 (1.09)3.53 (1.08)3.96 (1.18)
Control3.86 (1.07)4.03 (1.09)4.43 (0.90)
T statistic (significance)0.88 (0.38)6.22 (0.01)*4.80 (0.01)*
N220723466
  • Means reported in first two rows, with SD in parentheses. Note that n’s are different for each test due to different numbers of conditions.

  • *P<0.01.

  • HPV, human papilloma virus; PrEP, pre-exposure prophylaxis.